Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
European Journal of Medical Research
|
May 12, 2000
Indication, outcome and follow up of intensive care in patients with HIV-infection
L Leifeld, J Rockstroh, S Skaide, et al.
European Journal of Medical Research
|
November 18, 2004
Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis
B Terjung, F Bogsch, R Klein, et al.
European Journal of Medical Research
|
October 16, 2007
Comparison of indinavir + ritonavir 600 + 100 mg vs. 400 + 100 mg BID combinations in HIV1-infected patients guided by therapeutic drug monitoring
J-C Wasmuth, E Rodermann, E Voigt, et al.
HIV Medicine
|
February 18, 2020
Switching tenofovir disoproxil fumarate to tenofovir alafenamide in a real life setting: what are the implications?
C Schwarze-Zander, H Piduhn, C Boesecke, et al.
European Journal of Medical Research
|
June 22, 2010
Transmission of human immunodeficiency virus I drug resistance - a case report. What are the clinical implications?
E Anadol, R Kaiser, J Verheyen, et al.
HIV Medicine
|
October 17, 2013
Screening colonoscopy in HIV-infected patients: high rates of mucosal abnormalities in a German HIV-infected cohort
A Kasapovic, C Boesecke, C Schwarze-Zander, et al.
European Journal of Medical Research
|
June 18, 2010
Transient elastography discloses identical distribution of liver fibrosis in chronic hepatitis C between HIV-negative and HIV-positive patients on HAART
F Grünhage, J-C Wasmuth, S Herkenrath, et al.
Journal of Internal Medicine
|
January 5, 2000
Influence of protease inhibitor therapy on lipoprotein metabolism
H K Berthold, K G Parhofer, M M Ritter, et al.
Nuklearmedizin. Nuclear Medicine
|
April 30, 2014
Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET
A Sabet, H Ahmadzadehfar, J Bruhman, et al.
HIV Medicine
|
November 26, 2002
First-line ritonavir/indinavir 100/800 mg twice daily plus nucleoside reverse transcriptase inhibitors in a German multicentre study: 48-week results
E Voigt, A Wickesberg, J-C Wasmuth, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
European Journal of Medical Research
|
May 12, 2000
Indication, outcome and follow up of intensive care in patients with HIV-infection
L Leifeld, J Rockstroh, S Skaide, et al.
European Journal of Medical Research
|
November 18, 2004
Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis
B Terjung, F Bogsch, R Klein, et al.
European Journal of Medical Research
|
October 16, 2007
Comparison of indinavir + ritonavir 600 + 100 mg vs. 400 + 100 mg BID combinations in HIV1-infected patients guided by therapeutic drug monitoring
J-C Wasmuth, E Rodermann, E Voigt, et al.
HIV Medicine
|
February 18, 2020
Switching tenofovir disoproxil fumarate to tenofovir alafenamide in a real life setting: what are the implications?
C Schwarze-Zander, H Piduhn, C Boesecke, et al.
European Journal of Medical Research
|
June 22, 2010
Transmission of human immunodeficiency virus I drug resistance - a case report. What are the clinical implications?
E Anadol, R Kaiser, J Verheyen, et al.
HIV Medicine
|
October 17, 2013
Screening colonoscopy in HIV-infected patients: high rates of mucosal abnormalities in a German HIV-infected cohort
A Kasapovic, C Boesecke, C Schwarze-Zander, et al.
European Journal of Medical Research
|
June 18, 2010
Transient elastography discloses identical distribution of liver fibrosis in chronic hepatitis C between HIV-negative and HIV-positive patients on HAART
F Grünhage, J-C Wasmuth, S Herkenrath, et al.
Journal of Internal Medicine
|
January 5, 2000
Influence of protease inhibitor therapy on lipoprotein metabolism
H K Berthold, K G Parhofer, M M Ritter, et al.
Nuklearmedizin. Nuclear Medicine
|
April 30, 2014
Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET
A Sabet, H Ahmadzadehfar, J Bruhman, et al.
HIV Medicine
|
November 26, 2002
First-line ritonavir/indinavir 100/800 mg twice daily plus nucleoside reverse transcriptase inhibitors in a German multicentre study: 48-week results
E Voigt, A Wickesberg, J-C Wasmuth, et al.
Page
of 6